A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Clinical trial NCT07178171 · RECRUITING

Trial details

NCT number: NCT07178171
Sponsor: Xijing Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

TNBC, Triple Negative Breast Cancer

Start date: 2025-11-06
Primary completion: 2027-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.